• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Healthcare Capital Corp. (Amendment)

    2/4/22 6:13:55 AM ET
    $HCCC
    Get the next $HCCC alert in real time by email
    SC 13G/A 1 d461513dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

     

    Healthcare Capital Corp.

    (Name of Issuer)

    Class A Common Stock, par value $.0001 per share

    (Title of Class of Securities)

    42228C101

    (CUSIP Number)

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the Following Pages)

    (Page 1 of 8 Pages)

     

     

     


    Page 2 of 8

    CUSIP No. 42228C101

     

      1.    

      NAMES OF REPORTING PERSONS

     

      LINDEN CAPITAL L.P.

      2.  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3.  

      SEC USE ONLY

     

      4.  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Bermuda

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

      SOLE VOTING POWER

     

      0

       6.  

      SHARED VOTING POWER

     

      1,345,809

       7.  

      SOLE DISPOSITIVE POWER

     

      0

       8.  

      SHARED DISPOSITIVE POWER

     

      1,345,809

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,345,809

    10.  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      4.9%

    12.  

      TYPE OF REPORTING PERSON

     

      PN


    Page 3 of 8

    CUSIP No. 42228C101

     

      1.    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      LINDEN GP LLC

      2.  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3.  

      SEC USE ONLY

     

      4.  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

      SOLE VOTING POWER

     

      0

       6.  

      SHARED VOTING POWER

     

      1,345,809

       7.  

      SOLE DISPOSITIVE POWER

     

      0

       8.  

      SHARED DISPOSITIVE POWER

     

      1,345,809

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,345,809

    10.  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      4.9%

    12.  

      TYPE OF REPORTING PERSON

     

      HC


    Page 4 of 8

    CUSIP No. 42228C101

     

      1.    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      LINDEN ADVISORS LP

      2.  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3.  

      SEC USE ONLY

     

      4.  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

      SOLE VOTING POWER

     

      0

       6.  

      SHARED VOTING POWER

     

      1,431,624

       7.  

      SOLE DISPOSITIVE POWER

     

      0

       8.  

      SHARED DISPOSITIVE POWER

     

      1,431,624

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,431,624

    10.  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      5.2%

    12.  

      TYPE OF REPORTING PERSON

     

      IA, PN


    Page 5 of 8

    CUSIP No. 42228C101

     

      1.    

      NAMES OF REPORTING PERSONS

      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

      SIU MIN WONG

      2.  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3.  

      SEC USE ONLY

     

      4.  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      China (Hong Kong) and USA

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5.    

      SOLE VOTING POWER

     

      0

       6.  

      SHARED VOTING POWER

     

      1,431,624

       7.  

      SOLE DISPOSITIVE POWER

     

      0

       8.  

      SHARED DISPOSITIVE POWER

     

      1,431,624

      9.    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      1,431,624

    10.  

      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

      ☐

    11.  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      5.2%

    12.  

      TYPE OF REPORTING PERSON

     

      IN, HC


    Page 6 of 8

     

    This Amendment No. 1 (“Amendment No. 1”) is filed pursuant to Rule 13d-2(b) promulgated under the Securities Exchange Act of 1934, as amended, with respect to the Class A Common Stock, par value $.0001 per share (the “Shares”), of Healthcare Capital Corp. (the “Issuer”) beneficially owned by the Reporting Persons specified herein as of December 31, 2021, and amends and supplements the Schedule 13G filed January 29, 2021 (the “Schedule 13G”). Except as set forth herein, the Schedule 13G is unmodified.

    The names of the persons filing this statement on Amendment No. 1 are: Linden Capital L.P., a Bermuda limited partnership (“Linden Capital”), Linden Advisors LP, a Delaware limited partnership (“Linden Advisors”), Linden GP LLC, a Delaware limited liability company (“Linden GP”), and Mr. Siu Min (Joe) Wong (“Mr. Wong,” and collectively, the “Reporting Persons”).

     

    Item 4.

    Ownership:

     

    Item 4(a)

    Amount Beneficially Owned:

    As of December 31, 2021, each of Linden Advisors and Mr. Wong may be deemed the beneficial owner of 1,431,624 Shares. This amount consists of 1,345,809 Shares held by Linden Capital and 85,815 Shares held by separately managed accounts. As of December 31, 2021, each of Linden GP and Linden Capital may be deemed the beneficial owner of the 1,345,809 Shares held by Linden Capital.

     

    Item 4(b)

    Percent of Class:

    As of December 31, 2021, each of Linden Advisors and Mr. Wong may be deemed the beneficial owner of approximately 5.2% of Shares outstanding, and each of Linden GP and Linden Capital may be deemed the beneficial owner of approximately 4.9% of Shares outstanding. These percentages are based on 27,500,000 Shares outstanding based on disclosures by the issuer in its quarterly report on Form 10-Q filed on November 15, 2021.

     

    Item 4(c)

    Number of Shares as to which such person has:

     

    As of December 31, 2021:

      

    Linden Capital and Linden GP:

    (i) Sole power to vote or direct the vote:

         0  

    (ii) Shared power to vote or direct the vote:

         1,345,809  

    (iii) Sole power to dispose or direct the disposition of:

         0  

    (iv) Shared power to dispose or direct the disposition of:

         1,345,809  


    Page 7 of 8

     

    Linden Advisors and Mr. Wong:

      

    (i) Sole power to vote or direct the vote:

         0  

    (ii) Shared power to vote or direct the vote:

         1,431,624  

    (iii) Sole power to dispose or direct the disposition of:

         0  

    (iv) Shared power to dispose or direct the disposition of:

         1,431,624  

     

    Item 5.

    Ownership of Five Percent or Less of a Class:

    Not applicable.

     

    Item 10.

    Certification:

    By signing below, the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Sec. 240.14a-11.


    Page 8 of 8

     

    SIGNATURES

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

    Dated: February 2, 2022

     

    LINDEN CAPITAL L.P.
    By: Linden GP LLC, its general partner
      By:  

    /S/ Saul Ahn

        Saul Ahn,
        Authorized Signatory
    LINDEN GP LLC
    By:  

    /S/ Saul Ahn

        Saul Ahn,
        Authorized Signatory
    LINDEN ADVISORS LP
    By:  

    /S/ Saul Ahn

        Saul Ahn,
        General Counsel
    SIU MIN WONG
    By:  

    /S/ Saul Ahn

      Saul Ahn, Attorney-in-Fact for Siu Min Wong**

     

    **

    Duly authorized under Siu Min Wong’s Power of Attorney, dated June 10, 2019, incorporated herein by reference to Exhibit B of the statement on Schedule 13G filed by Linden Capital L.P. on June 19, 2019 in respect of its holdings in Haymaker Acquisition Corp II.

    Get the next $HCCC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HCCC

    DatePrice TargetRatingAnalyst
    1/24/2022$18.00Buy
    Ladenburg Thalmann
    More analyst ratings

    $HCCC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

    JERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. (NASDAQ:HCCC) ("HCCC"), a special purpose acquisition company, announced today the successful closing of the previously announced business combination (the "Business Combination"). The combined company will continue to be led by Alpha Tau's existing management team. Alpha Tau's ordinary shares and warrants are expected to begin trading on Tuesday, March 8, 2022, on Nasdaq under the ticker symbols "DRTS" and "DRTSW," respectively. The transaction, and the various proposals giving effect ther

    3/7/22 8:32:00 AM ET
    $HCCC

    Healthcare Capital Corp. and Alpha Tau Medical Ltd. Announce Stockholder Approval of the Business Combination

    NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) --  Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") and Alpha Tau Medical Ltd. ("Alpha Tau"), an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors, today announced that in its special meeting held on February 18, 2022, HCCC's stockholders voted to approve the previously announced proposed business combination (the "Business Combination") of HCCC and Alpha Tau. Approximately 94.57% of the votes cast at the meeting, representing approximately 65.64% of HCCC's outstanding shares as of the record date, voted

    2/22/22 7:30:00 AM ET
    $HCCC

    Healthcare Capital Corp. Announces Adjournment of Special Meeting of Stockholders

    NEW YORK, NY, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp. (NASDAQ:HCCC, HCCCW, and HCCCU))) ("HCCC") today announced that on February 18, 2022, it convened and then adjourned, without conducting any other business, its special meeting of stockholders (the "Special Meeting"). The Special Meeting has been adjourned until February 18, 2022 at 4:00p.m. Eastern Time (the "Adjournment"). The Special Meeting is being held to approve the business combination (the "Business Combination") with Alpha Tau Medical Ltd. ("Alpha Tau") and related proposals, as described in HCCC's definitive proxy statement filed with the Securities and Exchange Commission ("SEC") on January 14, 2022. The

    2/18/22 11:38:11 AM ET
    $HCCC

    $HCCC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ladenburg Thalmann initiated coverage on Healthcare Capital with a new price target

    Ladenburg Thalmann initiated coverage of Healthcare Capital with a rating of Buy and set a new price target of $18.00

    1/24/22 7:16:23 AM ET
    $HCCC

    $HCCC
    SEC Filings

    View All

    SEC Form 25-NSE filed by Healthcare Capital Corp.

    25-NSE - Healthcare Capital Corp/DE (0001822935) (Subject)

    3/7/22 4:22:12 PM ET
    $HCCC

    Healthcare Capital Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Healthcare Capital Corp/DE (0001822935) (Filer)

    2/22/22 4:05:34 PM ET
    $HCCC

    SEC Form 425 filed by Healthcare Capital Corp.

    425 - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/18/22 1:10:14 PM ET
    $HCCC

    $HCCC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Milch David Mark converted options into 1,923,925 shares and disposed of 1,923,925 shares

    4 - Healthcare Capital Corp/DE (0001822935) (Issuer)

    3/9/22 9:30:25 PM ET
    $HCCC

    SEC Form 4: Doyle Michael was granted 2,500 units of Common Stock

    4 - VISION HYDROGEN Corp (0001676580) (Issuer)

    5/14/21 1:08:25 PM ET
    $HCCC

    SEC Form 4: BENTON CHARLES F was granted 2,500 units of Common Stock

    4 - VISION HYDROGEN Corp (0001676580) (Issuer)

    5/14/21 1:06:11 PM ET
    $HCCC

    $HCCC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Healthcare Capital Corp. (Amendment)

    SC 13G/A - Healthcare Capital Corp/DE (0001822935) (Subject)

    3/9/22 11:16:23 AM ET
    $HCCC

    SEC Form SC 13G filed by Healthcare Capital Corp.

    SC 13G - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/18/22 4:13:27 PM ET
    $HCCC

    SEC Form SC 13G filed by Healthcare Capital Corp.

    SC 13G - Healthcare Capital Corp/DE (0001822935) (Subject)

    2/14/22 4:01:26 PM ET
    $HCCC